TTL Beteiligungs- und Grundbesitz-AG
TTL Beteiligungs- und Grundbesitz-AG
- WKN: 750100
- ISIN: DE0007501009
- Land: Deutschland
Nachricht vom 20.09.2021 | 08:15
TTL Beteiligungs- und Grundbesitz-AG: TTL - Subscription period for capital increase starts today
DGAP-News: TTL Beteiligungs- und Grundbesitz-AG
/ Key word(s): Capital Increase
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN.
TTL - Subscription period for capital increase starts today
TTL Beteiligungs- und Grundbesitz-AG ("TTL", "TTL AG") (ISIN DE0007501009) starts today with the subscription period for its capital increase with subscription rights announced on 15 September 2021 by ad hoc release.
The share capital is to be increased by up to 3,512,500 EUR from 21,075,000 EUR to up to 24,587,500 EUR by issuing up to 3,512,500 new no-par value bearer shares ("New Shares") in a cash capital increase from Authorised Capital. Existing shareholders may subscribe for New Shares at the subscription price of 2.25 Euro per share by exercising their subscription rights at a subscription ratio of 6:1. The subscription period, which started today, runs until 4 October 2021 (12 noon). The New Shares are fully entitled to dividends as of 1 January 2021.
"TTL took an important step towards future growth in the first half of 2021 by increasing its stake in Montano Real Estate GmbH to 50 percent. On this basis, we want to continue our course and expand our portfolio with further yield-strong investments," says Theo Reichert, CEO of TTL AG. "The company has made the decision to carry out a capital increase with subscription rights enabling TTL shareholders to participate in TTL's further growth," explains Reichert additionally.
The subscription rights from the capital increase are generally transferable, but there is no trading in subscription rights on the stock exchange. A purchase or sale of subscription rights via the stock exchange is therefore not possible.
TTL reserves the right to offer unsubscribed New Shares to a limited number of investors in a private placement at a price of 2.25 Euro. In the event that shareholders do not exercise subscription rights within the subscription period, the major shareholder AR Holding GmbH has committed to subscribe to the remaining New Shares in a private placement at the subscription price.
The subscription offer was published in the German Federal Gazette (Bundesanzeiger) on 17 September 2021 and is available for download on the TTL AG website at the following address: www.ttl-ag.de/de/KE2021.
TTL Beteiligungs- und Grundbesitz-AG (ISIN DE0007501009/Stock exchange symbol TTO) is a listed holding company focusing on the German real estate market. As a holding company, its aim is to enter into profitable investments, to accompany and develop them in order to participate in their value enhancement and to sustainably increase the earning power of TTL AG in the interest of its shareholders. TTL invests in both privately held and listed real estate companies with high dividends. In addition, TTL also participates in real estate projects and properties via platforms, whereby TTL Group provides mezzanine financing for these investments in addition to equity.
The Munich-based company is via TTL Real Estate GmbH invested in listed high-dividend real estate companies, primarily DIC Asset AG. At the same time, the company engages itself in real estate project developments, value-add properties and portfolios and plans to invest in further real estate portfolios in the future. Since the end of 2020, TTL AG holds a stake in the real estate management company Montano Real Estate GmbH, which is also based in Munich.
The information contained herein is not for release, directly or indirectly, in or into the United States of America, Australia, Canada or Japan. This document (and the information contained herein) does not contain or constitute an offer of securities for sale, or solicitation of an offer to purchase securities, in the United States, Australia, Canada or Japan or any other jurisdiction where such an offer or solicitation would be unlawful.
The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended ("Securities Act"), and may not be offered or sold in the United States unless the securities are registered under the Securities Act, or an exemption from the registration requirements of the Securities Act is available. No public offering of the securities will be made in the United States.
This document constitutes neither an offer to sell nor a solicitation to buy or subscribe for securities.
Statements contained herein may constitute "forward-looking statements". Forward-looking statements are generally identifiable by the use of the words "may", "will", "should", "plan", "expect", "anticipate", "estimate", "believe", "intend", "project", "goal" or "target" or the negative of these words or other variations on these words or comparable terminology.
Forward-looking statements involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. The Company does not undertake publicly to update or revise any forward-looking statement that may be made herein, whether as a result of new information, future events or otherwise.
|Company:||TTL Beteiligungs- und Grundbesitz-AG|
|Phone:||+49 (0)89 381611-0|
|Fax:||+49 (0)89 3915-92|
|Listed:||Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1234387|
|End of News||DGAP News Service|
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
04. Dezember 07:15 Bitcoin & Co: Brutaler Abverkauf – ist die Party jetzt vorbei?
04. Dezember 08:00 Top-Tipp Derivate: Luxus in der Warteschleife
04. Dezember 08:05 China-Aktien, Bitcoin & Co: Risiko-Assets werden verkauft
04. Dezember 08:45 Deutsche Telekom: 50 Prozent Potenzial - wann gelingt die Trendwende?
05. Dezember 07:00 Diese Token sind heißer als Bitcoin
News im Fokus
Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an
03. Dezember 2021, 07:03
FY 2020/2021 Financial Results
16. Dezember 2021
Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen
02. Dezember 2021